Study at a glance
What question did the studies ask?
Why can vitamin D have different effects in different tissues? Ten studies examined how cells make or break down active vitamin D and how selected cell and gene responses change.
What did they find?
The answer depended on the cell, its state, the timing and its surroundings. Some local changes were not matched by changes in blood. Two mouse studies disagreed about local intestinal gene responses after removal of a breakdown enzyme.
What does this mean?
A blood test cannot describe every local process. Making active hormone, changing a gene message and changing tissue function need separate measurements. The responding cell and the way its DNA is packaged also matter.
What are the limits?
Most evidence came from laboratory cells and altered mice. It does not establish how much hormone every human tissue makes or removes, a supplement dose or a general health benefit. Conflicting and unchanged results remain part of the answer.
Read the full article below ↓Different tissues can handle vitamin D differently, but a local biochemical change does not automatically mean better tissue function. This summary follows ten studies of vitamin D activation and breakdown, then connects them with the broader evidence on cell-specific gene responses. It explains what researchers measured and why several important questions remain unresolved. For the full comparison of the evidence, see Tissue-Specific Vitamin D Metabolism and Gene Responses: Full Study.
What needs to happen before a cell responds?
A circulating starting compound, 25-hydroxyvitamin D, can be converted into calcitriol, the active hormone. CYP27B1 helps perform that conversion; CYP24A1 helps break down vitamin D compounds. Detecting an enzyme or its RNA message does not measure how quickly it works. Processing and location of the protein matter too. The pathway is introduced in Vitamin D Enzyme Pathways (CYP27B1 / CYP24A1).
A concentration tells us how much is present. A rate tells us how much is being made, removed or moved over time. The same concentration can coexist with different rates. Finding conversion and a response in a group of cells also does not prove that every hormone molecule stayed inside its producer: released hormone may act on that cell or its neighbours. These distinctions underlie Vitamin D Metabolism at the Cellular Level and Vitamin D and Intracrine Activity.
Why do skin and immune-cell experiments give different answers?
Schauber’s skin experiments connected conversion and receptor activity with selected human antimicrobial and recognition-gene responses. But mouse Camp still rose after wounding when Cyp27b1 was absent, while the detected CD14 response was lost. Species differences therefore limit a universal explanation. The experiments did not demonstrate better clinical wound healing.
Kongsbak’s activated human T cells developed greater conversion capacity over several days. Blocking conversion reduced a precursor-associated CD38 response while preserving the response to supplied active hormone. Serum and binding protein reduced precursor availability. Villalba Lopez found faster and greater production in one laboratory macrophage state than another, with effects on neighbouring T-cell responses. The highest tested binding-protein level was below usual blood levels, and the laboratory state labels do not describe every tissue macrophage.
Chauss examined a defined T-cell response programme involving CYP27B1, VDR and CD46-associated activation. Blocking the IL6 receptor reduced both IL10 output and the phosphorylated, activated form of STAT3, without the same reduction in total STAT3. These are measured signalling and cytokine changes, not proof of general immune improvement or recovery from disease.
Can a normal blood result hide a local difference?
Meyer’s 2024 chemical-imaging study supported active-hormone detection outside the kidney, particularly in spleen, when renal activation was strongly suppressed. Some splenic genes changed and others did not. Small imaging groups and limited spatial resolution left the exact producing cells and movement into blood unresolved.
Lee’s two kidney-targeting models maintained circulating active hormone within the normal-comparator range. Yet the more affected model showed higher parathyroid hormone and lower bone mineral density, with lower calcium in males. Its targeting also affected thyroid and parathyroid tissues. Remaining kidney activity, nonrenal production and reduced breakdown were not separately measured as rates.
Meyer’s 2019 metabolic tables likewise showed that changes in precursor and breakdown products could coexist with preserved selected blood measurements. These findings do not identify one compensating mechanism or prove that kidneys are unnecessary. They show why a maintained hormone concentration cannot stand in for all physiological outcomes. The broader topic is introduced in Tissue-Specific Vitamin D Metabolism.
What did the conflicting intestinal studies show?
Fuchs found that deleting the breakdown enzyme in kidney increased blood active hormone and mildly raised calcium. Intestinal deletion instead increased two local calcium-transport gene messages without a matching rise in blood vitamin D metabolites. Fleet’s intestinal model found no statistically significant change in those local messages or blood metabolites. The studies therefore agreed about the absence of a clear blood rise but differed locally.
Fuchs used adult induction and a longer follow-up; Fleet used constitutive intestinal deletion and younger assessment. Their calcium diets differed too. These differences suggest questions to test, not a demonstrated explanation of the disagreement. An unchanged result is not proof of equivalence, and gene messages are not direct calcium-absorption measurements.
Uga’s experiments added a protein-processing qualification: enzyme location and processing affected reporter responses. Related enzymes could also contribute in the tested cells. The mouse intervention removed the intestinal receptor rather than just one breakdown enzyme, so its blood-metabolite change could not be assigned exclusively to intestinal CYP24A1. The work did not measure normal human intestinal clearance.
Does local metabolism explain every tissue-specific gene response?
No. The broader gene-expression evidence also shows differences by gut segment, cell differentiation and measurement time. RNA and protein need not change together. Short uncontrolled blood-cell responses after vitamin D3 and a longer randomized trial with no clear gene-expression response answer different questions; neither isolates metabolism as the reason for their difference. These comparisons are explained in Vitamin D-Responsive Gene Expression Across Cells and Tissues: Study Summary.
The chromatin evidence concerns how DNA is packaged and accessible. Accessibility, receptor occupancy and chemical marks are different observations. Some responding regions were already accessible, and some accessibility changes were temporary. Limited replication and nominal or unchanged human findings constrain claims about lasting epigenetic memory. These shared reviews add regulatory context without becoming extra independent metabolic studies. See Vitamin D, Chromatin Accessibility and Epigenetic Marks: Study Summary for the separate regulatory evidence.
What is the useful conclusion?
Local availability, cell state, receptor partners and DNA regulation can all shape the response. The ten publications contain different experiments, but connected research programmes and some reused comparisons limit claims of independent replication. Several measurements within one paper do not create several studies.
The evidence supports conditional tissue responses while leaving important rates and causal steps unmeasured. It does not establish exclusive intracellular retention, a universal local target level, improved human health or a personal supplement regimen. A sound explanation keeps product detection, gene activity and physiological function distinct.
Sources
Related reading
Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice
Vitamin D regulates mineral homeostasis.
Original paper ↗Read more →Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging
Here, utilizing on-tissue chemical derivatization and matrix assisted laser desorption ionization-mass spectrometry imaging (MALDI-MSI), we investigated the distribution of 1,25(OH)2D3 and 25(OH)D3 in the kidney, liver, spleen, and thymus.
Original paper ↗Read more →The Role of Intestinal Cytochrome P450s in Vitamin D Metabolism
We evaluated CYP3A or CYP24A1 activities on vitamin D action in cultured cells.
Original paper ↗Read more →Vitamin D-binding protein controls T cell responses to vitamin D
In vitro studies have shown that the active form of vitamin D3, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), can regulate differentiation of CD4+ T cells by inhibiting Th1 and Th17 cell differentiation and promoting Th2 and Treg cell differentiation.
Original paper ↗Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Aqueous Extract of Mori Folium Exerts Bone Protective Effect Through Regulation of Calcium and Redox Homeostasis via PTH/VDR/CaBP and AGEs/RAGE/Nox4/NF-κB Signaling in Diabetic Rats
The present study is aimed to explore whether the aqueous extract of Mori Folium (MF) exhibits bone protective effect by regulating calcium and redox homeostasis in diabetic rats, and to identify the signaling pathways involved in this process.
Original paper ↗Read more →Association between 25-Hydroxyvitamin D, Parathyroid Hormone, Vitamin D and Calcium Intake, and Bone Density in Healthy Adult Women: A Cross-Sectional Analysis from the D-SOL Study
This cross-sectional analysis aimed to investigate the associations of 25(OH)D and plasma PTH concentrations with bone parameters, and potential confounders, in women living in a high (England) or low (Brazil) latitude country.
Original paper ↗Read more →Expanding Outcomes Beyond Chronic Kidney Disease-Mineral and Bone Disorder: A Propensity Score-Matched Analysis of Parathyroidectomy versus Calcimimetics in Dialysis Patients with Secondary Hyperparathyroidism
In patients with ESRD and severe SHPT, parathyroidectomy was associated with lower risks of mortality, mild cognitive impairment, and sepsis compared with calcimimetic therapy, while cardiovascular and fracture outcomes were comparable.
Original paper ↗Read more →High-phytate/low-calcium diet is a risk factor for crystal nephropathies, renal phosphate wasting, and bone loss
Phosphate overload contributes to mineral bone disorders that are associated with crystal nephropathies.
Original paper ↗Read more →Kidney cadmium levels and associations with urinary calcium and bone mineral density: a cross-sectional study in Sweden
The aim of this study was to explore the relation between kidney Cd and urinary calcium excretion, or bone mineral density.
Original paper ↗Read more →Persistent changes in calcium-regulating hormones and bone turnover markers in living kidney donors more than 20 years after donation
In our recent survey-based study, we found no increased risk of fractures of all types but observed significantly more vertebral fractures in LKDs compared with matched controls.
Original paper ↗Read more →The gap between calculated and actual calcium substitution during citrate anticoagulation in an immobilised patient on renal replacement therapy reflects the extent of bone loss: a case report
Demineralisation and bone density loss during immobilisation are known phenomena.
Original paper ↗Read more →The Importance of Biologically Active Vitamin D for Mineralization by Osteocytes After Parathyroidectomy for Renal Hyperparathyroidism
The importance of vitamin D in the mineralization by osteocytes was investigated in hemodialysis patients who underwent total parathyroidectomy (PTX) with immediate autotransplantation of diffuse hyperplastic parathyroid tissue.
Original paper ↗Read more →The predictive value of 24-hour urinary calcium for kidney stone risk in primary hyperparathyroidism: insight from a retrospective study of parathyroid adenoma cases
Primary hyperparathyroidism (PHPT) is associated with an increased risk of kidney stones.
Original paper ↗Read more →Vitamin D, Calcium, Parathyroid Hormone, and Sex Steroids in Bone Health and Effects of Aging
Bone health of the elderly is a major global health concern, since about 1 in 3 women and 1 in 5 men suffer from bone loss and fractures, often called osteoporosis, in old age.
Original paper ↗Read more →Tissue-Specific Vitamin D Metabolism and Gene Responses: Full Study
Ten studies examine local vitamin D activation, breakdown and tissue gene responses, including conflicting intestinal findings and the limits of blood tests.
Read more →Effects of 25-Hydroxyvitamin D3 Combined with Phytase and Probiotic on Calcium-Phosphorus Metabolism, Bone Development, and Growth Performance in Weaned Piglets
This study evaluated the effects of dietary 25-hydroxyvitamin D3 (25-OH-VD3) in combination with phytase and probiotics on mineral metabolism, bone development, and related molecular mechanisms in weaned piglets.
Original paper ↗Read more →Evaluation of Bone Mineral Metabolism in Pre-Dialysis Chronic Kidney Disease: Quantitative Computed Tomography vs. Dual-Energy Absorptiometry and Correlation with Bone Turnover Markers
Background and Objectives: Bone and mineral disease (BMD) is a prevalent complication of advanced chronic kidney disease (CKD).
Original paper ↗Read more →Postprandial metabolic responses of serum calcium, parathyroid hormone and C-telopeptide of type I collagen to three doses of calcium delivered in milk
The present study investigated Ca absorption patterns with increasing levels of fortification in milk, and the response to one dose of a Ca salt.
Original paper ↗Read more →R990G Polymorphism of Calcium Sensing Receptor Gene Is Associated with High Parathyroid Hormone Levels in Subjects with Vitamin D Deficiency: A Cross-Sectional Study
Single nucleotide polymorphisms (SNPs), R990G and A986S of the calcium sensing receptor (CaSR) gene, are shown to influence response of parathyroid hormone (PTH) in subjects with optimal vitamin D levels.
Original paper ↗Read more →Tissue-Specific Vitamin D Metabolism
Tissue-specific vitamin D metabolism explains how different organs locally activate and regulate vitamin D signalling, shaping biological effects beyond blood levels alone.
Read more →Original sources
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism
Published in Schauber J, Dorschner RA, Coda AB, et al. The Journal of clinical investigation (2007).
Publication details
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. Schauber J, Dorschner RA, Coda AB, et al. The Journal of clinical investigation. 2007;117(3):803 to 811. DOI: 10.1172/JCI30142.
Vitamin D-binding protein controls T cell responses to vitamin D
In vitro studies have shown that the active form of vitamin D3, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), can regulate differentiation of CD4+ T cells by inhibiting Th1 and Th17 cell differentiation and promoting Th2 and Treg cell differentiation.
Publication details
Vitamin D-binding protein controls T cell responses to vitamin D. Kongsbak M, von Essen MR, Levring TB, et al. BMC immunology. 2014;15:35. DOI: 10.1186/s12865-014-0035-2.
Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses
Published in Lopez DV, Al-Jaberi FAH, Woetmann A, et al. Frontiers in immunology (2021).
Publication details
Macrophages Control the Bioavailability of Vitamin D and Vitamin D-Regulated T Cell Responses. Lopez DV, Al-Jaberi FAH, Woetmann A, et al. Frontiers in immunology. 2021;12:722806. DOI: 10.3389/fimmu.2021.722806.
Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells
Published in Chauss D, Freiwald T, McGregor R, et al. Nature immunology (2022).
Publication details
Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Chauss D, Freiwald T, McGregor R, et al. Nature immunology. 2022;23(1):62 to 74. DOI: 10.1038/s41590-021-01080-3.
Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging
Here, utilizing on-tissue chemical derivatization and matrix assisted laser desorption ionization-mass spectrometry imaging (MALDI-MSI), we investigated the distribution of 1,25(OH)2D3 and 25(OH)D3 in the kidney, liver, spleen, and thymus.
Publication details
Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging. Meyer MB, Lee SM, Cichanski SR, et al. JCI insight. 2024;9(15):e181763. DOI: 10.1172/jci.insight.181763.
Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3
Published in Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology (2025).
Publication details
Kidney deletions of Cyp27b1 fail to reduce serum 1,25(OH)2D3. Lee SM, Cichanski SR, Pintozzi NG, et al. The Journal of steroid biochemistry and molecular biology. 2025;250:106734. DOI: 10.1016/j.jsbmb.2025.106734.
A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues
Published in Meyer MB, Lee SM, Carlson AH, et al. The Journal of biological chemistry (2019).
Publication details
A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues. Meyer MB, Lee SM, Carlson AH, et al. The Journal of biological chemistry. 2019;294(39):14467 to 14481. DOI: 10.1074/jbc.RA119.010173.
Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice
Vitamin D regulates mineral homeostasis.
Publication details
Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice. Fuchs MA, Grabner A, Shi M, et al. The Journal of clinical investigation. 2025;135(4):e179882. DOI: 10.1172/JCI179882.
The impact of inducible-whole body or intestine-specific Cyp24a1 gene knockout on vitamin D metabolism in mice
Published in Fleet JC, Watkins NM, Anderson PH, et al. The Journal of steroid biochemistry and molecular biology (2025).
Publication details
The impact of inducible-whole body or intestine-specific Cyp24a1 gene knockout on vitamin D metabolism in mice. Fleet JC, Watkins NM, Anderson PH, et al. The Journal of steroid biochemistry and molecular biology. 2025;250:106735. DOI: 10.1016/j.jsbmb.2025.106735.
The Role of Intestinal Cytochrome P450s in Vitamin D Metabolism
We evaluated CYP3A or CYP24A1 activities on vitamin D action in cultured cells.
Publication details
The Role of Intestinal Cytochrome P450s in Vitamin D Metabolism. Uga M, Kaneko I, Shiozaki Y, et al. Biomolecules. 2024;14(6):717. DOI: 10.3390/biom14060717.